Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Appili Therapeutics Inc (TO: APLI)

 
APLI Technical Analysis
4
As on 2nd Apr 2025 APLI STOCK Price closed @ 0.03 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.04 & Strong Sell for SHORT-TERM with Stoploss of 0.05 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

APLISTOCK Price

Open 0.03 Change Price %
High 0.03 1 Day -0.01 -25.00
Low 0.03 1 Week -0.01 -25.00
Close 0.03 1 Month -0.01 -25.00
Volume 170625 1 Year -0.02 -40.00
52 Week High 0.06 | 52 Week Low 0.02
 
TO Canada Most Active Stocks
YRI 7.89 0.13%
TD 85.82 1.10%
CTS 6.05 10.60%
BNS 68.10 1.51%
UEX 0.50 16.28%
AQN 7.48 1.63%
TRP 69.92 2.07%
MFC 46.35 1.96%
SJR-B 40.48 0.02%
BCE 31.24 -4.26%
 
TO Canada Top Gainers Stocks
CUB 0.21 950.00%
CUB 0.21 950.00%
GGA 0.03 50.00%
MIN 0.20 42.86%
MIN 0.20 42.86%
MIN 0.20 42.86%
MIN 0.20 42.86%
MIN 0.20 42.86%
SCY 0.04 33.33%
SCY 0.04 33.33%
 
TO Canada Top Losers Stocks
MOZ 0.16 -80.25%
MOZ 0.16 -80.25%
LEV 0.34 -29.17%
LEV 0.34 -29.17%
LEV 0.34 -29.17%
APLI 0.03 -25.00%
APLI 0.03 -25.00%
DIAM 0.06 -25.00%
XAM 0.04 -20.00%
XAM 0.04 -20.00%
 
 
APLI
Daily Charts		 APLI
Intraday Charts		 Whats New @
Bazaartrend		 APLI
Free Analysis
 
APLI Important Levels Intraday
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
 
APLI Forecast April 2025
Share
4th UP Forecast0.11
3rd UP Forecast0.08
2nd UP Forecast0.07
1st UP Forecast0.05
1st DOWN Forecast0.01
2nd DOWN Forecast-0.01
3rd DOWN Forecast-0.02
4th DOWN Forecast-0.05
 
APLI Weekly Forecast
4th UP Forecast0.07
3rd UP Forecast0.06
2nd UP Forecast0.05
1st UP Forecast0.04
1st DOWN Forecast0.02
2nd DOWN Forecast0.01
3rd DOWN Forecast0.00
4th DOWN Forecast-0.01
 
APLI Forecast2025
4th UP Forecast0.15
3rd UP Forecast0.11
2nd UP Forecast0.09
1st UP Forecast0.06
1st DOWN Forecast-0
2nd DOWN Forecast-0.03
3rd DOWN Forecast-0.05
4th DOWN Forecast-0.09
 
 
APLI Other Details
Segment EQ
Market Capital 53449572.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
APLI Address
APLI
 
APLI Latest News
 
Your Comments and Response on Appili Therapeutics Inc
 
APLI Business Profile
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective portfolio includes Favipiravir for pandemic influenza and COVID-19; ATI-2307, an antifungal candidate, which is in clinical stage for the treatment of cryptococcal meningitis and invasive candidiasis; ATI-1503 that develops a class of gram-negative targeting antibiotics; ATI-1501, a taste-masked liquid oral suspension formulation of an antibiotic, metronidazole; ATI-1701 is a live-attenuated vaccine for Francisella tularensis. The company has a strategic alliance with AiPharma Global Holdings LLC for the development of Avigan/Reeqonus (favipiravir). Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada. Address: #21-1344 Summer Street, Halifax, NS, Canada, B3H 0A8
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service